Helping you design, implement and execute renal research projects of all sizes.

Gain guidance from a renal research organization that understands patient care

We guide the development of protocols that complement the standard of care while mitigating cost and risk.

Simplified yet robust protocol design is especially important in renal clinical trials. Download our white paper to see how.

Focus on the most efficient path to approval

Frenova helps you determine how a product candidate will be used in the real world so you can take the most efficient pathway to approval.

We evaluate strategies and assess factors that could impact your research.

Rely on the F1RST Up® alliance of sites to accelerate study start up.

We evaluate strategies and assess factors that could impact your research.

Utilize the depth of the world’s most extensive patient database

Frenova provides exclusive access to FMCNA patient dialysis treatment data. Comprising data collected for more than 25 years, the database offers access to historical data on more than 980,000 dialysis patients, including data from the nearly 200,000 patients who are active today.

Obtain vital bioinformatics and analytics services to inform study design for:

Learn More

No other clinical development services provider has a more intimate understanding of patients affected by kidney disease and its comorbid conditions than we do.

When you need to conduct a complete renal clinical program, start with the patient in mind — and trust the partner that’s completely renal.

Related Resources


Research as Care

Speed is key in bringing new drugs to patients. Speed in clearing regulatory hurdles, gearing up to product launch, gaining...


Including All Stakeholders in the Clinical Ecosystem

The success of clinical research relies not only on patient centricity, but also on collaboration between all stakeholders within the...


Start with the Patient in Mind – Interview With Patient Partner Donnie King

Start with the patient in mind — let’s renew our resolve to represent those who participate in studies to advance...